Global tobacco giant Philip Morris International (PM) shocked the world a few years ago when it declared it would pursue a ...
While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International ...
Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...
Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...
Tobacco group Philip Morris (PM) has fired up some key analysts after posting strong Q4 earnings. Four-star TipRanks-rated ...
We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a ...
Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.
Jacek Olczak; Chief Executive Officer, Director; Philip Morris International Inc Emmanuel Babeau; Chief Financial Officer; Philip Morris International Inc Matthew Smith; Analyst; Stifel, Nicolaus & Co ...
Philip Morris International (NYSE:PM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” ...
Shares of Philip Morris International are on track for an all-time closing high, after the company reported strong sales growth for its Marlboro cigarettes and Zyn nicotine pouches. The tobacco c ...
With several lines of evidence pointing to possible tobacco and vape industry interference in Government, alarm bells are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results